PubMed Health⌕ Search

PubMed · 3114601

Neurofibromatosis.

Abstract

Neurofibromatosis (NF) is a spectrum of disorders that manifest in a variety of ways. As part of the NF spectrum, many different anatomic abnormalities can develop that cause neurologic problems. The central nervous system may be directly involved or may be affected by tumor impingement. Optic pathway gliomas may also occur. The multiple neurofibromas characteristic of the most common form of NF, Von Recklinghausen disease, have a propensity to grow anywhere along nerve pathways. Therefore, the peripheral nervous system can be extensively involved. The neurofibromas may range in size from small, circumscribed tumors to gigantic plexiform tumors that insinuate into adjacent normal tissues and may compromise their function. Other neurologic problems of a functional nature can occur as well: learning disabilities, seizures, incoordination, and sensory abnormalities, among others. Computerized tomography (CT) and magnetic resonance imaging (MRI) scans are valuable diagnostic studies for identification and follow-up of tumors and other neurologic problems that may be investigated with these techniques. Plain radiographs are useful for investigating skeletal abnormalities in the skull, the ribs, the spine, and the limbs. Neurologic studies, including electroencephalography (EEG), brain-stem evoked response (BSER) or auditory brain stem response (ABR), visual evoked response (VER), nerve conduction velocity (NCV), and electromyography (EMG) provide additional information regarding specific symptom-indicated problems.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

V M Riccardi. 1987. Neurofibromatosis.. https://pubmed.ncbi.nlm.nih.gov/3114601/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans↗

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans↗

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans↗